The researchers found that while restrictive intervention does appear to decrease the share of adolescents initiating cannabis use, there was no evidence of policy changes impacting the share of frequent cannabis users.
The cannabis sector has a growing interest in centrifugal partition chromatography (CPC). To find out more about this process and its future potential, Analytical Cannabis spoke with the head of a research laboratory at one of the leading CPC instrument manufacturers, RotaChrom Technologies.
Analytical Cannabis caught up with Prospiant, a leading US-based provider of “soil-to-oil” cannabis ecosystems for the cultivation, extraction, and refinement of cannabinoids.
The use of MDMA-assisted therapy for post-traumatic stress disorder (PTSD) has now proven itself in its first phase 3 clinical trial.
Cannabis-infused foods, drinks, lotions, and tinctures are growing in popularity. But how can producers guarantee they'll be made safely and reliably? Analytical Cannabis spoke to several manufacturers to find out.
Research shows understanding teen use helps develop effective prevention programs.
Study finds adults age 50 and older with functional impairments use medical cannabis more and are more likely to suffer from prescription opioid and tranquilizer/sedative use and misuse.
This comes after the FDA also recently allowed institutes to conduct clinical trials on MDMA and its therapeutic potential in treating PTSD.
Crucially, the scientists say, the benefits of the drug came without the cost of hallucinations, a side effect which may aggravate stress.